Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Although the role of the tumor microenvironment in the process of cancer progression has been extensively investigated, the contribution of different stromal components to tumor growth and/or evasion from immune surveillance is still only partially defined. In this study we analyzed fibroblasts derived from metastatic melanomas and provide evidence for their strong immunosuppressive activity. In coculture experiments, melanoma-derived fibroblasts sharply interfered with NK cell functions including cytotoxicity and cytokine production. Thus, both the IL-2-induced up-regulation of the surface expression of NKp44, NKp30, and DNAM-1 triggering receptors and the acquisition of cytolytic granules were inhibited in NK cells. This resulted in an impairment of the NK cell-mediated killing of melanoma target cells. Transwell cocultures and the use of specific inhibitors suggested that cell-to-cell contact was required for inducing DNAM-1 modulation. In contrast, modulation of NKp44 and NKp30 was due to PGE 2 released by fibroblasts during coculture. Normal skin fibroblasts could also partially affect NK cell phenotype and function. However, the inhibitory effect of tumor-derived fibroblasts was far stronger and directly correlated with their ability to produce PGE 2 either constitutively or upon induction by NK cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 3×
“The expression of FAP has been reported as a distinctive feature of activated fibroblasts (30).”
BackgroundHuman mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975 · cited 1×
“S4) expression indicate that neither tumor-derived nor normal fibroblasts were able to favor or to inhibit proliferation of known defined NK cell types (such as KIR , NKG2A , or CD56brightCD16 / NK cell subsets) (45).”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Phinney, D. G., & Prockop, D. J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0637 · Cited by 1,908
Human mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324 · cited 4×
“For example, induction of regulatory T cells (Tregs) or myeloid suppressor cells and/or production of several immunosuppressive factors [including arginase-1, NOS-2, IDO, or TGF- ] by tumor cells or components of tumor microenvironment may result in functional subversion of tumor-infiltrating immunocompetent cells (27…”
BackgroundInfluentialCell adhesion and signalling by cadherins and Ig-CAMs in cancer
Cavallaro, U., & Christofori, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1276 · Cited by 1,311
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K. M., Doherty, J. M., Mills, J. C., & Colonna, M. (2009) · Nature · doi:10.1038/nature07537 · Cited by 1,251
Self-citationParrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., et al. (2000) · Nature · doi:10.1038/35040504 · Cited by 1,224
Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C., & Moretta, L. (2008) · Blood · doi:10.1182/blood-2007-02-074997 · Cited by 1,146
Self-citationFernandez, N. C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M., Tursz, T., Maraskovsky, E., & Zitvogel, L. (1999) · Nature Medicine · doi:10.1038/7403 · Cited by 1,060
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Self-citationCastriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Self-citationFehniger, T. A., Shah, M. H., Turner, M. J., VanDeusen, J. B., Whitman, S. P., Cooper, M. A., Suzuki, K., Wechser, M., Goodsaid, F., & Caligiuri, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4511 · Cited by 652
Chiesa, M. D., Carlomagno, S., Frumento, G., Balsamo, M., Cantoni, C., Conte, R., Moretta, L., Moretta, A., & Vitale, M. (2006) · Blood · doi:10.1182/blood-2006-03-006700 · Cited by 399
Self-citationCarrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G. (2008) · Cancer · doi:10.1002/cncr.23239 · Cited by 379
Self-citationPogge von Strandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Böll, B., Simhadri, V. L., Borchmann, P., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.010 · Cited by 374
Chan, A., Hong, D.-L., Atzberger, A., Kollnberger, S., Filer, A. D., Buckley, C. D., McMichael, A., Enver, T., & Bowness, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.89 · Cited by 366
Lakshmikanth, T., Burke, S., Ali, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36022 · Cited by 347 · cited 1×
“This is in line with a recent report indicating the prominent role of NCR and DNAM-1 in the NKmediated recognition and killing of melanoma cells (3).”
ResultHaniffa, M. A., Wang, X.-N., Holtick, U., Rae, M., Isaacs, J. D., Dickinson, A. M., Hilkens, C. M. U., & Collin, M. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1595 · Cited by 346
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
Terme, M., Ullrich, E., Delahaye, N. F., Chaput, N., & Zitvogel, L. (2008) · Nature Immunology · doi:10.1038/ni1580 · Cited by 289
IL-18–induced CD83+CCR7+NK helper cells
Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., & Kalinski, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050128 · Cited by 286
Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction
Welte, S., Kuttruff, S., Waldhauer, I., & Steinle, A. (2006) · Nature Immunology · doi:10.1038/ni1402 · Cited by 260
Nazareth, M. R., Broderick, L., Simpson-Abelson, M. R., Kelleher, R. J., Yokota, S. J., & Bankert, R. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5552 · Cited by 259
Jones, S., Horwood, N., Cope, A., & Dazzi, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2824 · Cited by 242
Boles, K. S., Barchet, W., Diacovo, T., Cella, M., & Colonna, M. (2005) · Blood · doi:10.1182/blood-2005-02-0817 · Cited by 208
Moretta, A., Poggi, A., Pende, D., Tripodi, G., Orengo, A. M., Pella, N., Augugliaro, R., Bottino, C., Ciccone, E., & Moretta, L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1393 · Cited by 207
Self-citationThe fibroblast: Sentinel cell and local immune modulator in tumor tissue
Silzle, T., Randolph, G. J., Kreutz, M., & Kunz‐Schughart, L. A. (2004) · International Journal of Cancer · doi:10.1002/ijc.11542 · Cited by 185
Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil
Li, G., Satyamoorthy, K., Meier, F., Berking, C., Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206455 · Cited by 177
Early liaisons between cells of the innate immune system in inflamed peripheral tissues
Moretta, A., Marcenaro, E., Sivori, S., Chiesa, M. D., Vitale, M., & Moretta, L. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.09.008 · Cited by 174
Self-citationDifferent checkpoints in human NK-cell activation
MORETTA, L., BOTTINO, C., PENDE, D., VITALE, M., MINGARI, M., & MORETTA, A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.008 · Cited by 166
Self-citationPoggi, A., Prevosto, C., Massaro, A.-M., Negrini, S., Urbani, S., Pierri, I., Saccardi, R., Gobbi, M., & Zocchi, M. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6352 · Cited by 161
Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue
Silzle, T., Kreutz, M., Dobler, M. A., Brockhoff, G., Knuechel, R., & Kunz‐Schughart, L. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323057 · Cited by 142
Analysis of Cyclooxygenase 2 (COX-2) Expression During Malignant Melanoma Progression
Goulet, A.-C., Einsphar, J. G., & Alberts, D. S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.627 · Cited by 141
Galiè, M., Konstantinidou, G., Peroni, D., Scambi, I., Marchini, C., Lisi, V., Krampera, M., Magnani, P., Merigo, F., Montani, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210920 · Cited by 139
Vacca, P., Cantoni, C., Prato, C., Fulcheri, E., Moretta, A., Moretta, L., & Mingari, M. (2008) · International Immunology · doi:10.1093/intimm/dxn105 · Cited by 131
Self-citationZambello, R., Falco, M., Chiesa, M. D., Trentin, L., Carollo, D., Castriconi, R., Cannas, G., Carlomagno, S., Cabrelle, A., Lamy, T., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3898 · Cited by 117
Self-citationCOX-2 expression in malignant melanoma: a novel prognostic marker?
Becker, M. R., Siegelin, M. D., Rompel, R., Enk, A. H., & Gaiser, T. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e32831d7f52 · Cited by 96
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (2018) · The Journal of Immunology · doi:10.1093/jimmunol/200.7.2231 · Cited by 87
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases
Scordamaglia, F., Balsamo, M., Scordamaglia, A., Moretta, A., Mingari, M. C., Canonica, G. W., Moretta, L., & Vitale, M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.047 · Cited by 75
Self-citationFauriat, C., Moretta, A., Olive, D., & Costello, R. T. (2005) · Blood · doi:10.1182/blood-2005-03-1270 · Cited by 69
Self-citationIL-23 modulates CD56+/CD3- NK Cell and CD56+/CD3+ NK-like T Cell function differentially from IL-12
van de Wetering, D., de Paus, R. A., van Dissel, J. T., & van de Vosse, E. (2008) · International Immunology · doi:10.1093/intimm/dxn132 · Cited by 64
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
“[189], CAFs in melanoma reduce the expression of MICA/B (two ligands of NK-activating receptors) on tumor cells, thereby suppressing NKG2Ddependent cytotoxic activity and IFN-γ secretion.”
BackgroundHallmarks of cancer: Interactions with the tumor stroma
Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,141
Immunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01124 · Cited by 825
Metadata
- Authors
- Balsamo, M., Scordamaglia, F., Pietra, G., Manzini, C., Cantoni, C., Boitano, M., Queirolo, P., Vermi, W., Facchetti, F., Moretta, A., Moretta, L., Mingari, M. C., & Vitale, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-12-08
- Volume
- 106
- Issue
- 49
- Pages
- 20847-20852
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2005203470
- Cited by
- 330
- References
- 49
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.